Stifel Financial Corporation reported earnings for the fourth quarter of 2024, significantly surpassing analyst expectations.

Stifel lowered the firm’s price target on Intel (INTC) to $21 from $25 and keeps a Hold rating on the shares. Q4 results were above management ...

Q4 2024 Earnings Call Transcript January 29, 2025 Stifel Financial Corp. beats earnings expectations. Reported EPS is $2.23, ...

Stifel Nicolaus analyst Matthew Smith, CFA maintained a Buy rating on Altria Group (MO – Research Report) today and set a price target of ...

Stifel lowered the firm’s price target on Danaher (DHR) to $260 from $265 and keeps a Hold rating on the shares. Danaher ...

Stifel analyst David Grossman raised the firm’s price target on IBM (IBM) to $271 from $246 and keeps a Buy rating on the ...

While total segment revenue declined 6.6% year-over-year due to weak truckload (TL) demand and lower rates, gross margins ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of ...

The firm’s CEO cited a “very competitive” recruiting market in 2024, but forecasts a better 2025 as longer-term efforts pay ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

The natural beauty of West Virginia will be celebrated both musically and visually in the Wheeling Symphony Orchestra’s upcoming performance, “Nature. Beauty.” Set for 2 p.m., Feb. 8, at the Capitol ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $125.6, a high estimate of $135.00, and a low estimate of $115.00. This upward trend is evident, ...